The Boston Globe Names Kyruus a Top Place to Work for 2020

Protheragen Offers Acquisition Opportunity for A Complete Pentapeptide Library

Data Analysis at AI & Medicine: PrediXcan Based Analysis and BSLMM Prediction

Alfa Chemistry Testing Lab: Pharmaceutical Impurity Testing Services to Assist Drug Development

Creative BioMart Supports Immunology Study with a Wide Selection of Adaptive Immunity Proteins

Page & Page and Partners appoints two new creatives following successful 2020

London, UK. 14th December 2020: Page & Page and Partners, the global creative communications agency specialising in health, wellness, and lifestyle, is today announcing the appointment of two new full-time staff. The new joiners are: Kirstie Turner – Writer and editor and Georgie Epps – Mid weight creative.

Plus Therapeutics Completes Sixth Dosing Cohort in ReSPECT™

IntelyCare Announces Record Growth and Momentum; Meets Surging Demand for Nursing Professionals in Post-Acute Space with Industry-Leading Data Science Approach

IntelyCare reports record growth in 2020 amid surging demand for data science-driven staffing technology in the post-acute market.

Grant awarded to Qlucore to aid clinical diagnostics of cancer

Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics, is working with leading scientific experts at Lund University (Sweden), Gothenburg University (Sweden) and in China to develop new diagnostics methods and software solutions to significantly improve disease stratification and treatment selection of patients diagnosed with cancer.

Hendrick Health Deploys 2bPrecise Precision Health Platform

Samsung Biologics breaks ground on Super Plant, the world’s largest and most innovative bio-manufacturing facility

Idifarma partners with industry expert to strengthen spray drying expertise

Sterling announces strategic investment in ADC Biotechnology

iVexSol Announces Series A Funding

iVexSol, a Worcester, MA-based manufacturer of lentiviral vector (LVV), announced a $13.0M Series A funding round. LVV is a critical raw material in the development of important new cell and gene therapies. iVexSol’s technology can reliably produce LVV at significantly greater quantities than traditional processes, enabling a smaller manufacturing footprint, and facilitating the rapid scale-out needed for global demand. The funding will be used to establish a cGMP manufacturing facility in Lexington, MA.

Innovate UK Funded Project Produces Next-Generation AI Drug Discovery Platform

Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research

Neuroglee Therapeutics to Attack Alzheimer’s Disease Through Personalized AI-Powered Digital Therapeutics

• Start-up to leverage gamification and cognitive rehabilitation targeting cognition, mood and behaviors in patients with mild-to-moderate Alzheimer’s disease • Digital therapeutics solution collects digital biomarkers via computer tablets in the home to assess and monitor cognitive function, thereby delivering personalized cognitive intervention • Can be prescribed as a stand-alone therapeutic or as combination therapy with a drug

IDBS launches Polar™ in a new product category that aims to streamline and speed up biopharmaceutical development

New Study Confirms VisualDx’s AI Improves Diagnostic Accuracy at the Point of Care

A new study reveals that VisualDx's artificial intelligence solution identifies skin conditions with 68% accuracy across all skin types.

KROHNE OPTIMASS 6400 Coriolis Mass Flowmeter Used in Covid-19 Vaccine Production Process

The press release announces it has supplied KROHNE OPTIMASS 6400 Coriolis mass flowmeters for measuring purified water used in Covid-19 vaccine production processes. The meters will also be used as a master meter – the standard by which all other production process flow meters will be verified against.

InSysBio to release CYTOCON DB Open version

InSysBio presents public version of CYTOCON DB entitled “CYTOCON DB Open”. Actually, CYTOCON DB Open has the same functionality as the initial version. However, CYTOCON DB Open is reduced and will be updated once per year. It concerns both content and functionality.